Across TCGA pan-cancer cohorts, TRBJ2-3 RNA is linked to patient survival in 24 of 34 cancer types, making it the most broadly survival-associated TRBJ2-3 data layer.
The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where higher TRBJ2-3 RNA is associated with better disease-free survival. In most high-consensus cancer types, elevated TRBJ2-3 expression acts as an unfavorable survival marker, although some lineages such as UCEC and SKCM show a favorable association.
UCEC, SKCM, and HNSC are the cancer types where TRBJ2-3 RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.